a16z Bio + Health Profile Banner
a16z Bio + Health Profile
a16z Bio + Health

@a16zBioHealth

Followers
3,393
Following
108
Media
46
Statuses
428

Backing bold entrepreneurs who are engineering biology and reimagining healthcare.

Joined September 2019
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@a16zBioHealth
a16z Bio + Health
1 year
“The #1 missing element in healthcare is trust.” On a new episode of Bio Eats World, @mcuban and @vijaypande unravel the costly inefficiencies of the healthcare market and unpack Mark's ideas for transparent, patient-centered innovation. Listen now 👇
12
10
65
@a16zBioHealth
a16z Bio + Health
8 months
LLMs could be tuned to serve as virtual healthcare navigators, providing accurate information, empathetic guidance, and even facilitating appointment bookings and payment processes while escalating high-risk cases to human professionals. @julesyoo and @daisydwolf see the
9
13
61
@a16zBioHealth
a16z Bio + Health
7 months
"I don't back an AI, I always back people leveraging AI." Recently, @a16z General Partner  @vintweeta joined the @Forbes Healthcare Summit stage with Bessemer's @morgancheatham , Abridge's @ShivdevRao , and @insitro 's @DaphneKoller to share the importance of investing in people as
Tweet media one
2
18
49
@a16zBioHealth
a16z Bio + Health
6 months
🎉 Bio Eats World is now Raising Health 🎉 A myriad of AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health, a podcast by a16z bio+health, hosted by Kris Tatiossian
1
4
39
@a16zBioHealth
a16z Bio + Health
6 months
AI's role in life sciences is multifaceted and evolving. It's reshaping everything from drug discovery to biomanufacturing, signaling a new era of innovation. @vijaypande , @beckypferdehirt , @Bryan__Faust , and @zakdoric say that AI will have the largest impact on: 🧬
1
1
11
@a16zBioHealth
a16z Bio + Health
2 years
In our latest Bio Eats World episode, @vijaypande and @pmarca dive into expert AI: As data and complexities for physicians increase, could AI be used as a superpower? Watch the full video. 👇
2
7
39
@a16zBioHealth
a16z Bio + Health
5 months
Recently, a16z Bio + Health Venture Partner @WillShrank joined @MHExecutive to discuss the personalization of healthcare, and the pivotal role of health tech startups in enhancing patient care. Ultimately, he believes the better use of technology will improve the humanity of how
Tweet media one
1
2
10
@a16zBioHealth
a16z Bio + Health
1 year
Patient engagement is lagging and clinicians are burned out—but what if every patient, provider, and staff member could interact with an immediately available, context-aware AI? Read more about why we're excited to back Hippocratic AI here:
1
9
30
@a16zBioHealth
a16z Bio + Health
2 years
At what point should a founder hire a dedicated BD leader? And how do you find the right one? @a16z Bio + Health's executive networks partner Beth Newman and BD partner @GingerLiau share their detailed thought process and their MOC framework.
0
8
29
@a16zBioHealth
a16z Bio + Health
9 months
There's a lot of excitement about #AI 's potential in healthcare, but the stakes are high. Healthcare tasks are highly complex & unforgiving of mistakes. Poor deployment can hurt people. Healthcare is arguably the most complicated space for deploying AI, per @JayRughani &
2
4
30
@a16zBioHealth
a16z Bio + Health
1 year
Check out @daisydwolf , @julesyoo , @omooretweets , and @conniechan 's new contribution to the @a16z Marketplace 100: Healthcare marketplaces, where are thou?
1
2
30
@a16zBioHealth
a16z Bio + Health
1 year
How do we build patient trust and ensure better outcomes in an inefficient healthcare market? On a new Bio Eats World, @mcuban shares his ideas with  @vijaypande on how to build innovative healthcare companies centered around transparency. Listen now 👇
2
10
27
@a16zBioHealth
a16z Bio + Health
1 year
Latest piece from @julesyoo , @daisydwolf , @dhaber , @mandrusko1 , and @annie_m_collins : why we’re on the edge of a healthcare x fintech revolution.
Tweet media one
0
4
30
@a16zBioHealth
a16z Bio + Health
1 year
Congratulations to @pomelocare ! We're excited to have backed this team from day one, through Seed and now Series A financing. Pomelo is building and scaling their value-based, virtual maternity and neonatal care platform ... 👇(1/2)
2
4
28
@a16zBioHealth
a16z Bio + Health
2 months
Though it might be surprising - A majority of doctors adopted electronic health records (EHRs) relatively recently, following the HITECH Act As a result, we are still in the early stages of having digital patient data over time and the full potential of these datasets remains
7
4
29
@a16zBioHealth
a16z Bio + Health
6 months
We want to be able to site-specifically insert DNA anywhere in the genome, in any cell type, with controlled expression. That's the holy grail of programmable genomic integration. Recently, a16z Bio+Health general partner @JorgeCondeBio sat with the leaders building toward that
1
4
16
@a16zBioHealth
a16z Bio + Health
9 months
Congrats to Mana Bio & co-founder Yogev Debbi on completing their oversubscribed seed round! Mana Bio is pioneering an approach integrating ML into cycles of design, build, test & learn to engineer customized LNPs accelerating genetic therapies.
0
5
28
@a16zBioHealth
a16z Bio + Health
2 years
Congratulations to @SynonymBio and team on launching Capacitor, a comprehensive database of microbial fermentation facilities worldwide.
@SynonymBio
synonym.bio
2 years
With @GoodFoodInst , @bluehorizoncorp and @materialinnov , we just launched @CapacitorBio , a powerful, free database of fermentation infrastructure built for the synbio community to find capacity to scale! 🎉 To learn more, check out this blog post:
0
1
11
1
3
20
@a16zBioHealth
a16z Bio + Health
7 months
"We haven't even tapped the level of complexity nature has proven can exist." - @vintweeta , @a16z general partner AI-enabled drug discovery is revealing new therapeutic possibilities hidden within the vast complexity of biological systems, paving the way for the future of
2
5
27
@a16zBioHealth
a16z Bio + Health
1 year
Who will be the Google, Amazon, Facebook, and Apple for bio? The new era of industrialized bio—propelled by AI—is transforming biology toward more engineered approaches, and we are poised to unleash the next industrial revolution in human history:
2
7
25
@a16zBioHealth
a16z Bio + Health
7 months
@vijaypande , of a16z Bio+Health, recently gave us all a deep dive on deep learning. In his conversation with AI researcher and Professor at Stanford University @drfeifei , the two broke down the expansive world of AI at the intersection of bio, healthcare, and tech. Check out
0
4
25
@a16zBioHealth
a16z Bio + Health
1 year
On #BioEatsWorld , @pmarca makes a case for the power of #AI . It's not just a tool, it's the gateway to enhanced quality of life. Fear shouldn't stand in the way of progress. Listen now 👇
3
6
24
@a16zBioHealth
a16z Bio + Health
1 month
Every year, nearly 2M new cancer diagnoses occur in the US alone and each diagnosis involves histological classification by pathologists. What if AI could help us uncover hidden insights in these images, predicting disease progression and therapy responses? That is precisely what
Tweet media one
1
7
25
@a16zBioHealth
a16z Bio + Health
8 months
Congratulations to Gate Bioscience! We're excited to have backed such an extraordinary team. Gate Bioscience is building a new class of small molecules called Molecular Gates. If Molecular Gates can be engineered for many high-value targets, they could represent a massive new
1
6
24
@a16zBioHealth
a16z Bio + Health
1 year
A few months ago, @vintweeta spoke with @McKinsey about AI in drug discovery — how her experience as a physician-scientist has shown her where it's most needed, the iterative loop between labs and ML, and the best applications of AI in drug development.
1
9
22
@a16zBioHealth
a16z Bio + Health
1 year
#AI holds promise for #biotech & #healthcare , but how can #policymakers harness it responsibly? Explore 3 key considerations 👇🏼 ✍🏽: @vijaypande @JayRughani @CF_Rom Jeff Clark
2
6
20
@a16zBioHealth
a16z Bio + Health
2 years
Our latest Digital Health Builders playbook is live! This time, @julesyoo and @daisydwolf tackle the topic of selling to SMBs with three founders to learn how they approach this go-to-market motion.
1
6
22
@a16zBioHealth
a16z Bio + Health
5 months
Imagine a 3D food printer available in your home tailored to your personal preferences, your nutritional status, and your microbiome. @julesyoo imagines the possibilities.
3
1
20
@a16zBioHealth
a16z Bio + Health
1 year
Join us in welcoming Dr. Greg Verdine as a16z Bio + Health Venture Partner! With a record of academic leadership, innovative drug discovery & serial entrepreneurial success in biotech, he's a game-changer. More from @vintweeta + @JorgeCondeBio here:
2
8
20
@a16zBioHealth
a16z Bio + Health
1 year
In our latest Bio Eats World episode, @gregmeyersCIO chats with @jorgecondebio about how AI is changing biopharma—and how biopharma might adapt to harness AI. Check it out here, or wherever you get podcasts:
0
4
20
@a16zBioHealth
a16z Bio + Health
1 year
20 yrs ago, genome sequencing was met with apprehension. Now, it’s an essential tool in medicine. @vintweeta , GP of a16z Bio+Health sees AI in healthcare on a similar path. Catch her insights on AI for social good in healthcare at #BloombergTechSummit on June 22.
Tweet media one
1
3
21
@a16zBioHealth
a16z Bio + Health
7 months
We are only scratching the surface of what preventative, technology-infused, and convenient healthcare could look like one day. From smart doorways to smart mirrors, @julesyoo imagines the possibilities. Learn more about the future is health here:
1
4
21
@a16zBioHealth
a16z Bio + Health
5 months
Technological transformations in healthcare have consistently empowered physicians and improved patient care. Examples include electronic medical records, the democratization of genetic testing, and the discovery of so many biomarkers (both molecular and digital!) that can
1
7
17
@a16zBioHealth
a16z Bio + Health
4 months
The transition to real-time digital ecosystems in healthcare was helped along by pioneers like Julie Klapstein through her foundational work at @Availity and @MultiPlan_Inc .
2
0
5
@a16zBioHealth
a16z Bio + Health
7 months
We invite you to share our front row seat to the future. Accept your invitation here:  🎥 @deepcellbio | @BigHatBio 🎬 @chroniclecinema
1
2
21
@a16zBioHealth
a16z Bio + Health
1 year
Forecasting health like the weather? That’s @jeffkaditz of @qbioinc vision of the future! Leveraging physics and comp. science, he's creating your “digital twin” by taking MRIs into the digital age. @vijaypande #BioEatsWorld #HealthTech #digitaltwin
0
7
17
@a16zBioHealth
a16z Bio + Health
8 months
The integration of technology and AI in healthcare insurance is not only a pathway to efficiency but also a catalyst for innovative service delivery. @mariots , CEO and co-founder of @OscarHealth , shares with a16z's @julesyoo how to improve efficiency and real-time data
0
2
21
@a16zBioHealth
a16z Bio + Health
1 year
Congratulations to @memorahealth on today’s $30M strategic investment announcement!
@memorahealth
Memora Health
1 year
@generalcatalyst @NorthwellHealth 4/ We’re honored to have the continued support of @a16z @transformcptl @bfrist Frist Cressey Ventures with their follow-on investments as well. Learn more from @vintweeta ’s 2022 blog on why she continues to believe in Memora’s platform:
1
1
5
0
5
19
@a16zBioHealth
a16z Bio + Health
11 months
How to maximize AI’s potential in the clinic by understanding its inherent limitations: @vijaypande , a16z general partner, and @zakkohane of @harvardmed share potent insights on this episode of #BioEatsWorld
0
54
19
@a16zBioHealth
a16z Bio + Health
2 years
New episode of Bio Eats World, featuring @joshuamarch of @eatscifi in conversation with @vijaypande and @oliviawebbc to talk about the challenges and opportunities of designing biology in pursuit of cultivated meat...and what the future could look like.
0
5
17
@a16zBioHealth
a16z Bio + Health
6 months
Our current healthcare delivery and insurance system is not designed to be able to pay for or distribute cell & gene therapies at scale. Problems of today: 👉🏼 Incentive mismatches with current insurance models 👉🏼 Financial and geographic barriers to patient access 👉🏼 Complex
0
0
12
@a16zBioHealth
a16z Bio + Health
1 year
On our latest episode of Bio Eats World, @vijaypande and Jakob Uszkoreit of Inceptive discuss using AI to take biology further. Listen now 🎧👇
1
4
16
@a16zBioHealth
a16z Bio + Health
2 years
Congratulations to @BigHatBio on their collaboration with @Merck . It's exciting to see these two companies collaborate to develop safer, more effective antibody therapies leveraging both Merck's deep development expertise and BigHat's AI guided antibody discovery platform.
@BigHatBio
BigHat Biosciences
2 years
We are thrilled to share that BigHat and @Merck are working together on a research collaboration to advance next-generation antibody therapeutics to patients. Our co-founders @MarkDePristo and @peytongreenside spoke with @GabrielleMasso9 at @FierceBiotech . [See link in reply]
Tweet media one
2
9
32
0
2
17
@a16zBioHealth
a16z Bio + Health
6 months
Yesterday at @jpmorgan 's Healthcare Conference, a16z Bio+Health GP @julesyoo dove into what the year ahead will bring for AI in healthcare alongside industry leaders @suchisaria of Bayesian Health, @sethHain of Epic, and @peteratmsr of Microsoft. #JPM24 ICYMI, check out some of
@julesyoo
Julie Yoo
6 months
I'll be chatting with @suchisaria of @bayesianhealth , @sethHain of Epic, and @peteratmsr of @Microsoft about "AI in Healthcare: The Opportunity Ahead" - Monday 5:15 pm, in the Colonial Room at #JPM2024 . We'll cover the state of the state, regulatory landscape, and predictions
2
8
46
1
2
16
@a16zBioHealth
a16z Bio + Health
1 year
"Software is (finally!) absolutely eating the healthcare world." @julesyoo spoke with @CooleyLLP about her time in healthtech, the state of venture funding, and her industry predictions about the next few years. Read it here:
0
3
17
@a16zBioHealth
a16z Bio + Health
3 months
“If you look at something as simple as a protein. Proteins are a lot like a human language, they can be naturally represented as strings of letters, so if you take for example protein motifs and domains, they act a lot like the functional building blocks of a language, they’re
1
1
7
@a16zBioHealth
a16z Bio + Health
2 years
#HLTH is in full swing. As a former company founder, builder and operator, our own Bio + Health GP @JulesYoo kicked off the day sharing her thoughts, advice and lessons-learned for navigating uncertain markets.
Tweet media one
0
2
17
@a16zBioHealth
a16z Bio + Health
4 months
While a big, white, puffy healthcare robot like Baymax is a possible manifestation of the future front door to healthcare, perhaps a more realistic one is an LLM tied to a healthcare services marketplace. @julesyoo , a16z general partner, and @daisydwolf , a16z investment partner,
0
2
13
@a16zBioHealth
a16z Bio + Health
2 years
And that's a wrap on #hlth2022 . Thank you to @HLTHEVENT for an invigorating start to our week!
Tweet media one
Tweet media two
Tweet media three
0
1
17
@a16zBioHealth
a16z Bio + Health
1 year
In the latest #bioeatsworld episode, @bhorowitz , co-founder of @a16z , and @alighodsi , CEO of @databricks , delve into the realities of executive hiring. Learn about the most common reasons an exec fails, & what separates an executor from a creator 👉
1
4
16
@a16zBioHealth
a16z Bio + Health
6 months
Digital health has undergone a remarkable transformation over the past decade. In a revealing discussion between @seanduffy , CEO of @omadahealth , and a16z's @vijaypande , we hear firsthand experiences of the birth of an industry. Get the full insights on Raising Health (fma Bio
2
5
15
@a16zBioHealth
a16z Bio + Health
4 months
"At the end of the day, even the best AI models will fail without broad distribution and profitable monetization" - @julesyoo , a16z general partner.
1
0
5
@a16zBioHealth
a16z Bio + Health
1 year
Check out some of @julesyoo 's latest thoughts about building: "Tying equity investments from strategics to commercial commitments — it's a good game to play if you construct it in the right way," she told @axios about growth-stage health companies. (1/2)
1
3
16
@a16zBioHealth
a16z Bio + Health
9 months
Selling to health systems can be difficult for digital health companies. To help founders navigate the process, @julesyoo and @BassettNetwork ’s Paul Uhrig shared their advice for engaging with health systems. Check it out in @healthcaredive 👉
1
5
16
@a16zBioHealth
a16z Bio + Health
3 months
"We're in this transition from finding [drugs] to designing [drugs]" - Philip Tagari, CSO at @insitro . Phil recently joined @vijaypande , founding general partner at a16z Bio+Health, to discuss all things drug discovery and AI including: the evolution of drug discovery methods
1
3
16
@a16zBioHealth
a16z Bio + Health
2 months
How can we reform the US healthcare system? @vijaypande , founding general partner at a16z Bio+Health, outlines three essential improvements to transform our system: 👉🏼 Technological Advancement: Embracing AI and related next-gen technologies. 👉🏼 Regulatory Reform: Policy and
2
2
15
@a16zBioHealth
a16z Bio + Health
2 years
Listen to our new Bio Eats World episode, with @daisydwolf and Sarah Thomas of @samedayhealth_ chatting about regulation in telehealth, how to work with counsel, and more:
0
3
10
@a16zBioHealth
a16z Bio + Health
1 year
This week on Bio Eats World, @vijaypande dives deep with @daphnekoller of @insitro into the last few decades of progress in AI, and how she thinks about leveraging AI to drive new insights in biology. Check it out. 👇
0
2
15
@a16zBioHealth
a16z Bio + Health
1 year
In a new @axios piece, General Partner @julesyoo spoke with @erinbrodwin about the ways food-as-medicine is making healthcare more holistic, and how companies like @SeasonHealth are pioneering technologies that make healthy eating easier. Read more 👇
0
3
15
@a16zBioHealth
a16z Bio + Health
1 year
Congratulations to the team at Ambience for launching their fully automated AI-powered medical scribe today! The company’s platform AutoScribe is revolutionizing the way providers document patient visits to reduce clinician burnout. Learn more 👇
1
1
15
@a16zBioHealth
a16z Bio + Health
1 year
In today's Bio Eats World episode, @daisydwolf and @mandrusko1 chat with Optum Financial CEO Kurt Adams. Together, they talk improving the consumer experience with tech and what the future of fintech in healthcare might look like. Check it out here👇🎧
1
34
9
@a16zBioHealth
a16z Bio + Health
9 months
We're excited to welcome @SuryaGanguli as our newest Bio + Health Venture Partner! A pioneering leader in AI & neuroscience, Surya brings invaluable expertise in leveraging tech to advance healthcare. Read more from @vijaypande here:
0
3
14
@a16zBioHealth
a16z Bio + Health
2 years
Physician-scientist and author @EricTopol joins us on Bio Eats World to discuss where AI in healthcare is going, where AI can help patients and providers, and what needs to happen to achieve widespread adoption with our GPs @vijaypande and @vintweeta . 🎧
0
5
14
@a16zBioHealth
a16z Bio + Health
1 year
AI can transform health and medicine, but to do so, @vijaypande argues that we’ll need to invest in "specialist AIs" that train, learn and make nuanced decisions like our best physicians and drug developers. Read more in his newest piece for @time . 👇
0
2
14
@a16zBioHealth
a16z Bio + Health
11 months
In a chat with @vijaypande , Lloyd Minor, Dean of Medicine at Stanford, foresees a merger of biomedicine, tech, and AI reshaping healthcare and healthcare education. Listen to the full chat here :
1
2
12
@a16zBioHealth
a16z Bio + Health
2 months
On 5/16 at the #STATBreakthrough Summit West, @vijaypande will join @insitro ’s @DaphneKoller and @Novartis Institute For Biomedical Research’s Derek Lowe for a panel moderated by @statnews @matthewherper on setting expectations for AI in drug development. More 👇
Tweet media one
0
3
13
@a16zBioHealth
a16z Bio + Health
4 months
"The best doctor in principle could be available to everybody," says @vijaypande , founding general partner of a16z Bio+Health. By integrating AI and technology into healthcare, we have the potential to democratize access to premium medical services, enhancing the capacity and
0
0
13
@a16zBioHealth
a16z Bio + Health
2 years
Today at 2 pm PT on the Main Stage @HLTHEVENT joins @julesyoo and Amazon Health’s leaders @aaronmartinfc and @nworahayogu for a conversation you won’t want to miss. 🔥 #hlth2022
0
4
11
@a16zBioHealth
a16z Bio + Health
1 year
Now live on the a16z podcast, a cross-post with Bio Eats World! Hear @vijaypande and @magirichani of @nobellfoods chat about engineering soybeans to produce all kinds of cheese—it's the future!
4
4
11
@a16zBioHealth
a16z Bio + Health
9 months
The field of "digital biology" is transforming medicine; by using AI to analyze experimental data in conjunction with actual patient data we can have more shots on goal. @VijayPande and @DaphneKoller of @insitro break it down on #BioEatsWorld
0
3
13
@a16zBioHealth
a16z Bio + Health
9 months
Healthcare x AI = Precision medicine @TroyanskayaOlga , Professor of computer science at Princeton University, discussed with @vijaypande the pivotal role of integrating artificial intelligence with genomics to advance precision medicine. The burgeoning field of AI and machine
0
3
11
@a16zBioHealth
a16z Bio + Health
2 years
General Partner @julesyoo shares her healthcare predictions for 2023 with @BusinessInsider , including a wave of innovative startups focused on the individual and family marketplace.
0
0
12
@a16zBioHealth
a16z Bio + Health
2 years
How can the healthcare ecosystem make clinical trials more diverse and equitable? Join @vintweeta for a discussion at @HLTHEVENT with other health system leaders on how to improve representation in clinical research. 🗓️ 10 am PT at the Arena Stage. #hlth2022
0
3
11
@a16zBioHealth
a16z Bio + Health
1 year
How long can a (hypothetical) venture capitalist expect to live? In our latest Bio Eats World episode, listen to @kpfortney of @bioagelabs answer @vijaypande and @oliviawebbc about this, the biology of aging, and where the field is headed.
1
3
12
@a16zBioHealth
a16z Bio + Health
2 months
On 5/20 at @bstormhealth , @julesyoo will join @Microsoft ’s @peteratmsr and @harvardmed ’s @zakkohane for a discussion moderated by @chrissyfarr on the #GenerativeAI revolution in medicine. Learn more at
Tweet media one
0
1
12
@a16zBioHealth
a16z Bio + Health
2 months
By integrating AI with extensive genetic databases, researchers are not only speeding up the identification of viable drug targets but also enhancing the precision of clinical diagnostics and predictive modeling. Recently, @vijaypande , founding general partner of a16z
Tweet media one
0
2
11
@a16zBioHealth
a16z Bio + Health
8 months
Which therapeutic modalities win? As new modalities of medicines emerge, a race to find the most suited diseases for these therapies ensues, leading to crowded markets in certain disease indications. @BenPortney , @adelatomsejova , and @JorgeCondeBio condense it down to four
0
1
11
@a16zBioHealth
a16z Bio + Health
8 months
Advances in technology increasingly occur at the intersection of disciplines. @vijaypande , recently spoke with @enfeinberg , Founder and CEO of Genesis Therapeutics, about how he built a company that fosters collaboration between experts in complementary fields like biology,
0
1
11
@a16zBioHealth
a16z Bio + Health
6 months
a16z Bio+Health general partner @vintweeta is set to join Alexis Borisy, Laura Furmanski, Rogier Rooswinkel, @TimShannonMD , and John Wesley for today’s “Scaling Breakthroughs Forward” panel led by @SteveQYang at the #WuXiGlobalForum . Learn more:
0
0
5
@a16zBioHealth
a16z Bio + Health
2 months
Bravo to @valarlabs ! The Vesta test offers a promising new approach to bladder cancer treatment selection. It’s the first-ever computational histology AI assay for bladder cancer patients — and helps physicians match the right treatment regimens to the right patients.
@valarlabs
Valar Labs
2 months
Exciting news! Valar Labs is proud to announce #Vesta , the first histology-based test for predicting response to #BCG in #BladderCancer . Press Release:
1
13
22
0
3
11
@a16zBioHealth
a16z Bio + Health
2 months
Imagine a future where a healthcare robot can detect early signs of disease. Shortly thereafter, a drone delivers a personalized medicine tailored specifically to your genomic profile right to your doorstep. @julesyoo , a16z general partner, reimagines what preventative,
0
0
11
@a16zBioHealth
a16z Bio + Health
8 months
In the era where AI meets Health, navigating the regulatory framework is not just a compliance chore, but a gateway to trust and broader adoption. @suchisaria , Founder & CEO of @bayesianhealth , and @vijaypande , general partner of a16z Bio+Health, break it down: 👉🏼 Embrace
1
2
11
@a16zBioHealth
a16z Bio + Health
15 days
Integrating extensive personal health data with AI and the world’s health knowledge is the key to living 100 healthy years. @Function is leading this transformation by offering robust lab testing twice a year, covering over 100 biomarkers—far more than traditional annual
Tweet media one
0
0
13
@a16zBioHealth
a16z Bio + Health
1 year
“Fear of progress isn’t new and in some cases may be warranted. But if history is a guide, the hand wringing over AI will prove premature and misguided.” Read through @vijaypande 's latest @FortuneMagazine commentary for more on #AI ’s democratizing power:
0
2
9
@a16zBioHealth
a16z Bio + Health
2 months
Congratulations to @Dyno_Tx on their AI-focused collaboration with @nvidia !
@Dyno_Tx
Dyno Therapeutics, Inc.
2 months
We're excited to announce our collaboration with @nvidia . Working with the world’s leading computing company and building within NVIDIA's BioNeMo will accelerate Dyno's AI-powered sequence design and bring us all closer to helping patients with transformative new medicines.
Tweet media one
2
6
45
1
0
10
@a16zBioHealth
a16z Bio + Health
1 year
In our latest episode of Bio Eats World, @vintweeta chats with @njlittman of @biovergehq about her dual role as clinician and investor, her advice for entrepreneurs, and more. Check it out!
0
2
10
@a16zBioHealth
a16z Bio + Health
10 months
AI has huge potential in healthcare if developers understand the right "Jobs To Be Done." @jayrughani , @daisydwolf , @julesyoo , and @vijaypande say to focus on high-labor areas and build integrated suites solving buyers' top pain points. Learn more👇
0
0
10
@a16zBioHealth
a16z Bio + Health
2 months
Yesterday at #FortuneHealth , @julesyoo , @peteratmsr , and @zakkohane discussed how AI-powered tools are improving patients' lives, why regulatory rails offer healthcare a unique opportunity to improve these technologies, and what’s next for #GenAI in medicine.👇
1
0
10
@a16zBioHealth
a16z Bio + Health
10 months
Two AI pioneers, @AndrewYNg and @VijayPande , discuss the past, present & future of AI. Their discussions provide an insightful look at how AI has evolved and where it is headed next.
0
3
9
@a16zBioHealth
a16z Bio + Health
9 months
How to build a dream team between clinical & product? Key takeaways from @julesyoo 's conversation with @Reena_Pande & Peter Shalek: Embed clinical experts directly within product teams early, structure CMO & CPO as peers reporting to CEO to enable alignment, and more. Listen to
0
2
10
@a16zBioHealth
a16z Bio + Health
5 months
Max Cohen ( @zerogee ), co-founder of @sprinterhealth , and @erenbali , founder of @CarbonHealth , share their experiences transitioning from the tech industry to healthcare with a16z general partner, @julesyoo . Advice from Max and Eren to other tech founders eyeing the leap: 👉🏼
0
1
10
@a16zBioHealth
a16z Bio + Health
5 months
"We've chosen to apply engineering [to the problem] because if you start with Cas9, not only are you kind of weighed down by all of the baggage that that molecule has, you also are weighed down by the additional challenge of using it within the broader context of the field." -
1
3
10
@a16zBioHealth
a16z Bio + Health
7 months
Just as computers revolutionized Wall Street, transitioning trades from human brokers to algorithms, a similar wave of tech-enablement is poised to reshape the $4.3 trillion American healthcare sector with AI at the helm. Get the full insights from @daisydwolf , @adelatomsejova ,
0
2
10
@a16zBioHealth
a16z Bio + Health
1 month
M&B 693 was developed in Britain and first prescribed in 1938 to treat pneumonia. The most famous patient saved by the drug was British Prime Minister Winston Churchill, who contracted pneumonia at the height of the Second World War. The drug most likely saved his life and the
0
1
9
@a16zBioHealth
a16z Bio + Health
2 years
Catch up this weekend: Can companies solely rely on SMB sales to get to scale, or do they inevitably need to go upmarket (especially during challenging economic times)? We ask founders this question and many more in our newest GTM playbook.
0
1
8
@a16zBioHealth
a16z Bio + Health
1 year
It was an exciting week in San Francisco during #JPM23 ! A special thank you to our partners at @FierceBiotech , @McDermottLaw and #WuXiGlobalForum for hosting such insightful panels to kickoff the new year.
Tweet media one
Tweet media two
Tweet media three
0
2
9
@a16zBioHealth
a16z Bio + Health
26 days
The healthcare industry is experiencing a labor crisis, with a shortage of skilled professionals and burnout among existing workers. AI and other next-generation technologies offer a promising opportunity to alleviate both clinical and administrative burdens. By implementing
Tweet media one
0
0
9
@a16zBioHealth
a16z Bio + Health
2 months
“We are gradually moving, probably over a period of a decade, from something that looks more artisanal to something that looks more engineered.” @vijaypande shared his take on why, how, and when AI will impact drug development. More in @statnews 👇
0
3
9
@a16zBioHealth
a16z Bio + Health
1 year
Congratulations to @ZusHealthHQ ! We’re thrilled to be supporting Zus as they advance their shared health data platform to make patient data digestible and easy-to-use for healthcare providers. Learn more about their latest financing round and new partnership 👇
0
4
9